Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Leukemia

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2405020PMID 17989718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression.

  2007cited by this paper
• Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

  2007cited by this paper
• Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein

  2007cited by this paper
• Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-κB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner

  2007cited by this paper
• JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML

  2007cited by this paper
• Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts.

  2007cited by this paper
• The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

  2007cited by this paper
• Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis

  2006cited by this paper
• AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

  2006cited by this paper
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

  2006cited by this paper
• Erythropoietin activates caspase‐3 and downregulates CAD during erythroid differentiation in TF‐1 cells – A protection mechanism against DNA fragmentation

  2006cited by this paper
• Leukemogenic AML1‐ETO fusion protein upregulates expression of connexin 43: The role in AML1‐ETO‐induced growth arrest in leukemic cells

  2006cited by this paper
• Neural stem cell differentiation is dependent upon endogenous caspase‐3 activity

  2005cited by this paper
• Apoptosis-based therapies for hematologic malignancies.

  2005cited by this paper
• Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms.

  2005cited by this paper
• Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal

  2004cited by this paper
• Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

  2004cited by this paper
• Articles on similar topics can be found in the following Blood collections

  2004cited by this paper
• A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells.

  2004cited by this paper
• The 8;21 translocation in leukemogenesis

  2004cited by this paper
• Protein kinase C (cid:1) mediates retinoic acid and phorbol myristate acetate–induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation

  2004cited by this paper
• Williams–Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO

  2004cited by this paper
• Caspase activity and a specific cytochrome C are required for sperm differentiation in Drosophila.

  2003cited by this paper
• Non-apoptotic functions of caspases in cellular proliferation and differentiation.

  2003cited by this paper
• Many cuts to ruin: a comprehensive update of caspase substrates

  2003cited by this paper
• Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?

  2002cited by this paper
• Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis

  2002cited by this paper
• Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entity.

  2002cited by this paper
• AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

  2001cited by this paper
• Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation

  2001cited by this paper
• MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation*

  2001cited by this paper
• Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view.

  2001cited by this paper
• Fusion genes in leukemia: an emerging network

  2001cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  2000cited by this paper
• Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2

  1999cited by this paper
• Overexpression of the Nucleoporin CAN/NUP214 Induces Growth Arrest, Nucleocytoplasmic Transport Defects, and Apoptosis

  1998cited by this paper
• Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

  1998cited by this paper
• Establishment of a myeloid leukaemic cell line (SKNO‐1) from a patient with t(8;21) who acquired monosomy 17 during disease progression

  1995cited by this paper
• The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation

  1995cited by this paper
• Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

  1991cited by this paper

• Decoding the AML1/ETO Translocation Cipher: In-depth Exploration into the Pathogenesis and Cutting-edge Therapeutic Strategies of t(8;21) Acute Myeloid Leukemia.

  2025cites this paper
• Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells.

  2023cites this paper
• Protein‐Nanocaged Selenium Induces t(8;21) Leukemia Cell Differentiation via Epigenetic Regulation

  2023cites this paper
• SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells

  2021cites this paper
• Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias

  2021cites this paper
• Targeting miR‐193a‐AML1‐ETO‐β‐catenin axis by melatonin suppresses the self‐renewal of leukaemia stem cells in leukaemia with t (8;21) translocation

  2019cites this paper
• WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells

  2018cites this paper
• The t(8;21) fusion protein RUNX1-ETO downregulates PKM2 in acute myeloid leukemia cells

  2017cites this paper
• Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner.

  2017cites this paper
• Honokiol induces proteasomal degradation of AML1‐ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia

  2017influential citation
• Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein

  2016cites this paper
• Antiproliferating Activity of Esculetin on Acute Myeloid Leukemic Cell Line Potential Role in Therapy

  2015cites this paper
• Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors

  2014cites this paper
• Targeting peroxiredoxins against leukemia.

  2013cites this paper
• Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells.

  2013cites this paper
• Targeting of AML1-ETO in t(8;21) Leukemia by Oridonin Generates a Tumor Suppressor–Like Protein

  2012cites this paper
• Tao Zhen Like Protein − Tumor Suppressor Targeting of AML 1-ETO in t ( 8 ; 21 ) Leukemia by Oridonin Generates a

  2012cites this paper
• RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

  2012cites this paper
• Effector Caspases and Leukemia

  2011cites this paper
• Current advances in the application of proteomics in apoptosis research

  2011cites this paper
• Molecular mechanisms of leukemia-associated protein degradation

  2010cites this paper
• Active compounds-based discoveries about the differentiation and apoptosis of leukemic cells

  2009cites this paper
• PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells.

  2009cites this paper
• Protein Kinase Cδ Stimulates Proteasome-Dependent Degradation of C/EBPα during Apoptosis Induction of Leukemic Cells

  2009cites this paper
• Hypoxia-HIF-1alpha-C/EBPalpha/Runx1 signaling in leukemic cell differentiation.

  2009cites this paper